Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles
© 2023 The Authors..
We assessed a cohort of people living with human immunodeficiency virus (PLWH) (n = 110) and HIV negative controls (n = 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all timepoints, PLWH had significantly lower neutralizing antibody (nAb) titers than HIV-negative controls. We also observed a delayed development of neutralization in PLWH that was underpinned by a reduced frequency of spike-specific memory B cells (MBCs). Improved neutralization breadth was seen against the Omicron variant (BA.1) after the third vaccine dose in PLWH but lower nAb responses persisted and were associated with global MBC dysfunction. In contrast, SARS-CoV-2 vaccination induced robust T cell responses that cross-recognized variants in PLWH. Strikingly, individuals with low or absent neutralization had detectable functional T cell responses. These PLWH had reduced numbers of circulating T follicular helper cells and an enriched population of CXCR3+CD127+CD8+T cells after two doses of SARS-CoV-2 vaccination.
Errataetall: | |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
iScience - 26(2023), 1 vom: 20. Jan., Seite 105862 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Touizer, Emma [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 14.02.2024 published: Print-Electronic UpdateOf: bioRxiv. 2022 Nov 11;:. - PMID 36380764 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.isci.2022.105862 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM351022198 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM351022198 | ||
003 | DE-627 | ||
005 | 20240214232625.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.isci.2022.105862 |2 doi | |
028 | 5 | 2 | |a pubmed24n1292.xml |
035 | |a (DE-627)NLM351022198 | ||
035 | |a (NLM)36590902 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Touizer, Emma |e verfasserin |4 aut | |
245 | 1 | 0 | |a Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 14.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a UpdateOf: bioRxiv. 2022 Nov 11;:. - PMID 36380764 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2023 The Authors. | ||
520 | |a We assessed a cohort of people living with human immunodeficiency virus (PLWH) (n = 110) and HIV negative controls (n = 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all timepoints, PLWH had significantly lower neutralizing antibody (nAb) titers than HIV-negative controls. We also observed a delayed development of neutralization in PLWH that was underpinned by a reduced frequency of spike-specific memory B cells (MBCs). Improved neutralization breadth was seen against the Omicron variant (BA.1) after the third vaccine dose in PLWH but lower nAb responses persisted and were associated with global MBC dysfunction. In contrast, SARS-CoV-2 vaccination induced robust T cell responses that cross-recognized variants in PLWH. Strikingly, individuals with low or absent neutralization had detectable functional T cell responses. These PLWH had reduced numbers of circulating T follicular helper cells and an enriched population of CXCR3+CD127+CD8+T cells after two doses of SARS-CoV-2 vaccination | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Immunology | |
650 | 4 | |a Virology | |
700 | 1 | |a Alrubayyi, Aljawharah |e verfasserin |4 aut | |
700 | 1 | |a Ford, Rosemarie |e verfasserin |4 aut | |
700 | 1 | |a Hussain, Noshin |e verfasserin |4 aut | |
700 | 1 | |a Gerber, Pehuén Pereyra |e verfasserin |4 aut | |
700 | 1 | |a Shum, Hiu-Long |e verfasserin |4 aut | |
700 | 1 | |a Rees-Spear, Chloe |e verfasserin |4 aut | |
700 | 1 | |a Muir, Luke |e verfasserin |4 aut | |
700 | 1 | |a Gea-Mallorquí, Ester |e verfasserin |4 aut | |
700 | 1 | |a Kopycinski, Jakub |e verfasserin |4 aut | |
700 | 1 | |a Jankovic, Dylan |e verfasserin |4 aut | |
700 | 1 | |a Jeffery-Smith, Anna |e verfasserin |4 aut | |
700 | 1 | |a Pinder, Christopher L |e verfasserin |4 aut | |
700 | 1 | |a Fox, Thomas A |e verfasserin |4 aut | |
700 | 1 | |a Williams, Ian |e verfasserin |4 aut | |
700 | 1 | |a Mullender, Claire |e verfasserin |4 aut | |
700 | 1 | |a Maan, Irfaan |e verfasserin |4 aut | |
700 | 1 | |a Waters, Laura |e verfasserin |4 aut | |
700 | 1 | |a Johnson, Margaret |e verfasserin |4 aut | |
700 | 1 | |a Madge, Sara |e verfasserin |4 aut | |
700 | 1 | |a Youle, Michael |e verfasserin |4 aut | |
700 | 1 | |a Barber, Tristan J |e verfasserin |4 aut | |
700 | 1 | |a Burns, Fiona |e verfasserin |4 aut | |
700 | 1 | |a Kinloch, Sabine |e verfasserin |4 aut | |
700 | 1 | |a Rowland-Jones, Sarah |e verfasserin |4 aut | |
700 | 1 | |a Gilson, Richard |e verfasserin |4 aut | |
700 | 1 | |a Matheson, Nicholas J |e verfasserin |4 aut | |
700 | 1 | |a Morris, Emma |e verfasserin |4 aut | |
700 | 1 | |a Peppa, Dimitra |e verfasserin |4 aut | |
700 | 1 | |a McCoy, Laura E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t iScience |d 2018 |g 26(2023), 1 vom: 20. Jan., Seite 105862 |w (DE-627)NLM285332627 |x 2589-0042 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2023 |g number:1 |g day:20 |g month:01 |g pages:105862 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.isci.2022.105862 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2023 |e 1 |b 20 |c 01 |h 105862 |